August 28, 2020
The slew of voluntary recalls Nichi-Iko Pharmaceutical launched in April and May resulted from “pushing its production staff too hard” at a time when the company is focusing on expanding its lineup of in-house generics, President Yuichi Tamura told Jiho...read more